These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6046180)

  • 41. [Isolation of anthranilic acid derivatives from sibiromycin inactivation products].
    Rubasheva LM; Mezentsev AS; Vlasova TF; Anisimova OS
    Antibiotiki; 1973 Mar; 18(3):216-8. PubMed ID: 4764217
    [No Abstract]   [Full Text] [Related]  

  • 42. A new antitumor antibiotic, phenomycin.
    Nakamura S; Yajima T; Hamada M; Nishimura T; Ishizuka M
    J Antibiot (Tokyo); 1967 Jul; 20(4):210-6. PubMed ID: 6072895
    [No Abstract]   [Full Text] [Related]  

  • 43. [Isolation of 2'-dehydroverrucarin A as metabolite of Myrothecium roridum Tode ex Fr.,species type by Fries. Verrucarin and roridin, 13].
    Zürcher W; Tamm C
    Helv Chim Acta; 1966 Dec; 49(8):2594-7. PubMed ID: 6010054
    [No Abstract]   [Full Text] [Related]  

  • 44. C-terminal amino acid of neocarzinostatin.
    Maeda H; Koyanagi T; Ishida N
    Biochim Biophys Acta; 1968 Jun; 160(2):249-51. PubMed ID: 5658126
    [No Abstract]   [Full Text] [Related]  

  • 45. [Comparison of tauromycetin with red-violet indicator antibiotics].
    Fedorova GB; Brazhnikova MG
    Antibiotiki; 1969; 14(3):195-9. PubMed ID: 5404298
    [No Abstract]   [Full Text] [Related]  

  • 46. Thin-layer chromatographic determination of the antitumor agent 3,6-bis-(5-chloro-2-piperidinyl)-2,5-piperazinedione in fermentation broth.
    Issaq HJ; Chan JA; Barr EW
    J Chromatogr; 1978 May; 152(1):280-4. PubMed ID: 649749
    [No Abstract]   [Full Text] [Related]  

  • 47. Neocarzinostatin: carboxyl-terminal-43-peptide residue of apo-neocarzinostatin as the binding site of neocarzinostatin-chromophore.
    Edo K; Saito K; Akiyama Y; Mizugaki M; Koide Y; Ishida N
    Chem Pharm Bull (Tokyo); 1986 Dec; 34(12):5180-3. PubMed ID: 2952300
    [No Abstract]   [Full Text] [Related]  

  • 48. Conformational properties of polyformycin: a polyribonucleotide with individual residues in the syn conformation.
    Ward DC; Reich E
    Proc Natl Acad Sci U S A; 1968 Dec; 61(4):1494-501. PubMed ID: 4303481
    [No Abstract]   [Full Text] [Related]  

  • 49. [Spectrophotometric method for the determination of the content of bruneomycin in culture fluid and solutions].
    Ponomarenko VI
    Antibiotiki; 1971 Jan; 16(1):44-6. PubMed ID: 4994898
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effect of the molecular structure of natural anthracycline antibiotics on their relative hydrophobicity].
    Baranov EP; Brikenshteĭn VKh; Zaslavskiĭ BIu; Karasik GV; Mikheeva LM
    Bioorg Khim; 1988 Jan; 14(1):103-13. PubMed ID: 3164185
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Studies on antitumor antibiotic 1588, II. The physicochemical properties and the characteristics of the main components (author's transl)].
    Liu CJ; Kong QT; Wang ZY; Zhang YZ; Wang JX; Si ZD
    Yao Xue Xue Bao; 1981 Oct; 16(10):741-7. PubMed ID: 6175168
    [No Abstract]   [Full Text] [Related]  

  • 52. [Spectralphotometric studies on reciprocal action between chromomycin A 3 and nucleic acids].
    Behr W; Hartmann G
    Biochem Z; 1965 Dec; 343(4):519-27. PubMed ID: 5875445
    [No Abstract]   [Full Text] [Related]  

  • 53. Structure of carzinophilin. IV. Structure elucidation by nuclear magnetic resonance spectroscopy. (2).
    Onda M; Konda Y; Hatano A; Hata T; Omura S
    Chem Pharm Bull (Tokyo); 1984 Aug; 32(8):2995-3002. PubMed ID: 6518583
    [No Abstract]   [Full Text] [Related]  

  • 54. Chemical studies on bleomycins. I. The acid hydrolysis products of bleomycin A2.
    Takita T; Muraoka Y; Maeda K; Umezawa H
    J Antibiot (Tokyo); 1968 Jan; 21(1):79-80. PubMed ID: 5673299
    [No Abstract]   [Full Text] [Related]  

  • 55. Tautomerism of the nucleoside antibiotic formycin, as studied by carbon-13 nuclear magnetic resonance.
    Krugh TR
    J Am Chem Soc; 1973 Jul; 95(14):4761-2. PubMed ID: 4730666
    [No Abstract]   [Full Text] [Related]  

  • 56. Characterization of neocarzinostatin.
    Maeda H; Kumagai K; Ishida N
    J Antibiot (Tokyo); 1966 Nov; 19(6):253-9. PubMed ID: 6013238
    [No Abstract]   [Full Text] [Related]  

  • 57. [Results obtained in 6 cases of tumors treated with sarkomycin (an antitumoral antibiotic)].
    Sezer R
    Turk Tip Cemiy Mecm; 1966 Mar; 32(3):131-40. PubMed ID: 4287509
    [No Abstract]   [Full Text] [Related]  

  • 58. Gas chromatographic analysis of the Alternaria metabolite, tenuazonic acid.
    Harvan DJ; Pero RW
    J Chromatogr; 1974 Dec; 101(1):222-4. PubMed ID: 4374466
    [No Abstract]   [Full Text] [Related]  

  • 59. [Antineoplastic antibiotic 4418 related to the antibiotics of the group pluramyciniomycin].
    Kudinova MK; Babenko GA; Ukholina RS; Maksimova TS; Nechaeva NP; Terekhova LP; Rossolimo OK
    Antibiotiki; 1968 Mar; 13(3):201-5. PubMed ID: 5672120
    [No Abstract]   [Full Text] [Related]  

  • 60. [Chemical composition of retamycin, an antibiotic complex with anti-tumor activity produced by Streptomyces olidensis nov.sp.(IAUFPe 5622)].
    Delle Monache F; Marini-Bettòlo GB; Leoncio de Albuquerque I; De Andrade Lyra FD; Gonçalves da Lima O
    Ann Ist Super Sanita; 1970; 6(6):357-64. PubMed ID: 5526840
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.